MedImmune is wholly owned by AstraZeneca plc (LSE: AZN.L, NYSE: AZN) and is the worldwide biologics business for the AstraZeneca Group. The company has approximately 3,000 employees worldwide and is headquartered in Gaithersburg, Maryland. MedImmune strives to provide better medicines to... more

UCB is a global leader in the biopharmaceutical industry dedicated to the research, development and commercialization of innovative pharmaceutical and biotechnology products in the fields of central nervous system disorders, allergy/respiratory diseases, immune and inflammatory disorders... more

Advanced Life Sciences Holdings, Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of drugs in the areas of infectious disease, oncology and inflammation. The Company's has assembled a pipeline of clinical and preclinical product candidates in... more

Cubist Pharmaceuticals, Inc. (Cubist) is a biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment. The Company focuses on developing products for the anti-infective... more

Rib-X Pharmaceuticals is a New Haven, CT-based small molecule drug discovery and development company focused on the structure-based design of novel classes of anti-infective agents. Our technology platform is based on the high resolution crystal structure of the 50S subunit of the... more

Ambion RNA Diagnostics was created to provide RNA-based products and services to the in vitro diagnostic and pharmaceutical processing industries. Its state-of-the-art molecular biology laboratory is a cGMP multi-user, multi-product facility that includes fully equipped, process and... more

Inhibitex, Inc. is a biopharmaceutical company focused on the development of differentiated anti-infective products. It pursues pre-clinical or clinical-stage antiviral development programs via in-licensing or acquisition. On September 19, 2007, the Company completed the acquisition of... more

Replidyne, Inc. is a biopharmaceutical company focused on discovering, developing, in-licensing and commercializing anti-infective products. Its most advanced product candidate, faropenem medoxomil, is an oral, community antibiotic being developed for adult primary care and pediatric... more

At ActivBiotics, we are dedicated to achieving success through leadership and the unrelenting pursuit of scientific breakthrough. Our greatest asset is our people, and we are bringing together the brightest and most talented scientific professionals to the ActivBiotics team. If you are an... more

Cytovax Biotechnologies Inc. (TSX: CXB) is a biotechnology company focused on the development and commercialization of vaccines and therapeutic products for the prevention and treatment of significant infectious diseases with unmet clinical needs. Cytovax is developing new, effective... more

Vicuron Pharmaceuticals is an international biopharmaceutical company focused on discovering, developing, manufacturing and commercializing vital medicine for seriously ill patients. The company's lead products are in Phase III clinical trials and include anidulafungin, a novel antifungal... more

Diagnostic HYBRIDS innovates, develops, manufactures and markets cellular and molecular diagnostic kits for various applications in detecting a wide range of respiratory diseases, herpes infections, thyroid function, and other high value markers of disease. Our products provide an... more

Anacor Pharmaceuticals, Inc., formerly AnaMax, Inc., is a biopharmaceutical company developing small-molecule therapeutics derived from its boron chemistry platform. The Company has focused initially on developing topical applications of its compounds to treat fungal, bacterial and... more

IntraBiotics Pharmaceuticals, Inc., is a biopharmaceutical company engaged in the development of high-value anti-infectives, focused on solving medical problems for patients who currently have few or no satisfactory alternatives.

About Biophage Pharma Inc. Biophage Pharma Inc. is a Canadian biopharmaceutical company developing new therapeutic and diagnostic products using phage-based technology.

Axxima was founded in September 1997, at the Martinsried Biotech Center (IZB) in Munich (Germany), as "Virgene" and commenced business operations in May 1998, following completion of its first funding round. The principal scientific founder of the Company was Axel Ullrich, the... more

At Micrologix, we create partnerships that are based on shared visions, values, knowledge and expertise. This sharing adds value for each partner and paves the way to developing breakthrough drugs that provide solutions for unmet patient needs. Our goal is to develop win-win relationships... more

Paratek Pharmaceuticals, Inc. is a privately held biopharmaceutical company headquartered in Boston, MA, which is engaged in the discovery and commercialization of new therapeutics that treat life threatening infectious and other serious diseases. Paratek's mission at its founding was... more

Quorex Pharmaceuticals is discovering and developing first-in-class drugs to address the growing unmet need for new and effective therapies to treat serious bacterial infections. The company's proven discovery engine is making it possible to discover highly potent and selective compounds... more

Addex Pharmaceuticals SA is a Switzerland-based pharmaceutical company engaged in the discovery and development of therapeutic compounds for the treatment of central nervous system (CNS) disorders. The company has a pipeline of products in clinical or preclinical development for major... more

SIGA Technologies, Inc. (SIGA) is a biotechnology company that discovers, develops and commercializes anti-infectives for serious infectious diseases. The major focus of the Company's developmental and commercialization activities is on products for use in defense against biological... more

Antex Biologics, and its wholly owned subsidiary, AntexPharma, is a biopharmaceutical company committed to developing and marketing new products to prevent and treat infections and related diseases. The Company maintains strategic alliances with GlaxoSmithKline, Aventis Pasteur, and the... more

About Morphochem AG (www.morphochem.de): Morphochem was founded in 1998 and currently employs 45 staff in Munich, Germany and Basel, Switzerland. It has developed a unique and highly integrated chemical genomics drug discovery platform that it is applying to the development of a pipeline... more

Optimer Pharmaceuticals, Inc. (Optimer) is a biopharmaceutical company focused on discovering, developing and commercializing anti-infective products. The Company’s initial development efforts address products that treat gastrointestinal infections (GI) infections, and related diseases,... more

Affinium is a pharmaceutical company focused on the clinical development of antibacterials. Our lead development program encompasses a potent, orally available, novel antibiotic class for the treatment of antibiotic resistant staphylococcal infections. For information, please... more

ECI Biotech is a leading edge protein sensor company with strong intellectual property of particular value for diagnostic sensors and therapeutics. Founded in 1998, its technologies relate to the detection of microbial pathogens and stabilizing active proteins to protect against... more

Seattle-based PathoGenesis Corp. develops and commercializes drugs to treat chronic infectious diseases - particularly serious lung infections, including those common in cystic fibrosis, bronchiectasis and ventilator patients. PathoGenesis' stock is traded on the Nasdaq National Market... more

Enanta Pharmaceuticals is a research and development company that uses its novel chemistry approach and drug discovery capabilities to create best in class small molecule drugs in the anti-infective field. At the heart of Enanta is its commitment to innovative chemistry that surpasses... more

Oscient Pharmaceuticals Corporation is a commercial-stage pharmaceutical company marketing Food and Drug Administration (FDA) approved products in the United States. The Company markets two products: ANTARA (fenofibrate) capsules, a cardiovascular product, and FACTIVE (gemifloxacin... more

GeneSoft is a specialty pharmaceutical company focused on discovering and developing novel anti-infective products. The company was founded in 1998 by Peter Dervan, Ph.D. and others based on proprietary chemistry technology licensed from the California Institute of Technology. GeneSoft... more

At Inimex our goal is to attract the best and brightest candidates and provide them with challenging and exciting opportunities for career growth. We are committed to the personal and career development of our team members and believe strongly that our success is the direct result of... more

Mpex Pharmaceuticals is a clinical stage biopharmaceutical company whose mission is to develop important new therapies to combat the growing issue of antibiotic resistance. While much of the attention in the medical community has been focused on resistance in gram-positive pathogens such... more

ConjuGon was founded in 2001 by University of Wisconsin-Madison professors Marcin Filutowicz and Richard Burgess to develop products to combat the growing epidemic of antibiotic resistance. Today, the company has a dedicated team working on products to prevent and treat bacterial... more

Remedyne Corporation is a private biotechnology company focused on developing the next generation potent immune stimulating products to treat cancer and infectious disease. Remedyne's products are based upon the company's exclusive worldwide license to the DAM Technology developed by... more

Cumbre Pharmaceuticals is a research based specialty pharmaceutical company that discovers, develops and markets anti-infective products for the treatment of serious and life-threatening infections, particularly those caused by antibiotic resistant pathogens. Nearly every significant... more

Prolysis is an antibacterial drug discovery and development company with new classes of compounds in pre-clinical development. Novel antibacterial drugs are urgently needed to treat hospital-acquired and community-associated infections where existing therapies are failing due to... more

NovaBay Pharnaceuticals, Inc. (NovaBay) is a clinical stage biopharmaceutical company focused on developing product candidates for the treatment or prevention of different infections in hospital and non-hospital environments. The Company has discovered and is developing a class of... more

Arpida (SWX: ARPN) is a biopharmaceutical company headquartered in Reinach, Switzerland with operations in Switzerland and the USA. It focuses on the discovery, development and commercialisation of novel drugs that seek to overcome the growing problem of microbial resistance. The most... more

PhageTech is a private, venture-backed biopharmaceutical company focused on the discovery and development of new classes of antibiotic drugs for novel antibacterial targets, based on its world-leading efforts in phage genomics. By unraveling the genetic code of phages, or bacterial... more

Microcide was founded in December 1992 to discover, develop and commercialize novel antibiotics for the treatment of serious bacterial infections. For over three years, Microcide has been applying its proprietary Targeted Genomics technology whereby it creates and uses bacterial and... more

Versicor Inc. is an international biopharmaceutical company focused on discovering, developing, manufacturing and commercializing novel, broad-spectrum antibiotic and antifungal agents with distinct competitive advantages. The company's lead products are in Phase III clinical trials and... more

Imugene Limited (Imugene) is principally engaged in the research, development and commercialization of animal health technologies in Australia. In May 2008, Imugene announced that a trial conducted in collaboration with Abic Biological Laboratories Teva Ltd (Abic) testing variations of... more

eMetagen is a drug discovery company producing new pharmaceuticals from uncultivated soil microorganisms. The company discovers new antibiotics for development with partners and licensees and also markets its Gene and Pathway Banksâ„¢ as tools for drug discovery. eMetagen antibiotics... more

SinusPharma is a development company taking promising proprietary medication formulations, developed by the Company, through the FDA investigational new drug application process for the treatment of chronic sinusitis. The Company will focus on obtaining manufacturing and marketing... more

We are a small molecule, anti-infective company. Microbiotix, Inc. is a privately held, product-focused biopharmaceutical company engaged in the discovery and development of novel small molecule, anti-infective drugs that address commercially significant medical markets. The company... more

GangaGen Biotechnologies Pvt Ltd (GBPL) is developing proprietary phage products to treat infections caused by staphylococcus bacteria, including nasal, urinary tract, and pseudomonas aeruginosa infection in burns and wounds.

Achaogen (a-KAY-oh-jen) specializes in the discovery and development of small molecules to treat infections caused by bacteria, and by antibiotic-resistant strains in particular. Achaogen focuses on high value bacterial targets that are validated, but not yet addressed by safe and... more